Related Articles
Effect of bortezomib in combination with cisplatin and 5‑fluorouracil on 4T1 breast cancer cells
A novel combination treatment for breast cancer cells involving BAPTA-AM and proteasome inhibitor bortezomib
Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line
Effects of 3-butenyl isothiocyanate on phenotypically different prostate cancer cells
The proteasome inhibitor, bortezomib, induces prostate cancer cell death by suppressing the expression of prostate-specific membrane antigen, as well as androgen receptor